Cannim
Cannim is a private Australian medical cannabis company that imports, manufactures, and distributes premium branded cannabis products (dried flower, tinctures, vapes) via pharmacy networks and wholly owned telehealth clinics across Australia, UK, USA, and Canada, while conducting university-partnered research on alternative medicines.
- Company typePrivate
- Founded2017
- HeadquartersSydney, Australia
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Cannim does
Cannim is a privately held Australian medical cannabis company that manufactures, imports, and distributes premium branded cannabis products — including dried flower, tinctures, and vapes — marketed through four sub-brands (Lumir, High Country, Humming Bud, and Helix) for patients seeking alternatives to conventional medicine. The company sells B2B into Australian pharmacies via a dedicated portal with regulatory onboarding (AHPRA verification, Schedule 8 approvals) and 30-day payment terms, and operates three wholly owned telehealth clinics — Lumir Clinic UK (CQC-licensed, hosted at the University of Birmingham), Lumir Clinic USA (veteran-run), and Natura Clinic in Australia — providing direct-to-patient consultations for chronic and persistent conditions. Geographically, Cannim imports and distributes into legal medical cannabis markets across Australia, UK, USA, and Canada, with headquarters in Manly, Sydney, and regional hubs in Great Malvern and Birmingham, UK.
Cannim's stated technology layer is "AI-enabled research" conducted under research program approvals in the US, UK, and Australia, in partnership with Western Sydney University, University of Birmingham, University of South Florida, St. Louis University, and the National Institute of Integrative Medicine (NICM). The company also offers the THC Calculator, a free clinical decision-support tool that helps Australian doctors manage prescribing within TGA daily limits. The Lumir sub-brand is anchored scientifically by Professor Lumir Hanuš, the discoverer of Anandamide, who sits on Cannim's medical advisory board. The company's go-to-market combines direct sales to pharmacies, field/enterprise sales, and direct-to-consumer telehealth, with the THC Calculator serving as a top-of-funnel prescriber engagement channel.
Cannim firmographics
Firmographics- Name
- Cannim
- Legal name
- Cannim Group
- Website
- https://cannim.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Cannim is a private Australian medical cannabis company that imports, manufactures, and distributes premium branded cannabis products (dried flower, tinctures, vapes) via pharmacy networks and wholly owned telehealth clinics across Australia, UK, USA, and Canada, while conducting university-partnered research on alternative medicines.
- Ownership category
- akta.pro rank
Cannim industry classification
Industry- Product category
- Medical Cannabis
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)
Keywords
Where Cannim is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
Cannim business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Medical Cannabis Product Sales: Cannim imports and distributes medical cannabis products including dried flower, tinctures, and vapes through their Lumir and High Country brands. Products are sold to pharmacies which then dispense to patients with valid prescriptions.
- Telehealth Clinic Services: The company operates its own telehealth clinic solutions (Lumir Clinic UK and USA) providing medical consultations and holistic medical solutions to patients with persistent conditions. In the USA, Lumir Clinic specifically serves veterans' unique needs.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Cannim product offering
Product offeringCore offering
Cannim imports and distributes premium medical cannabis products (dried flower, tinctures, vapes) under proprietary brands Lumir, High Country, Humming Bud, and Helix into Australia, the UK, and USA. It also operates wholly-owned telehealth clinics (Lumir Clinic UK, Lumir Clinic USA, Natura Clinic Australia) delivering direct-to-patient consultations and dispensing for chronic and persistent conditions, alongside AI-enabled research programs demonstrating efficacy of cannabis and psilocybin-based therapies.
Product overview
Cannim is a leader in emerging plant-based and holistic therapies, combining research, global supply chain expertise, and direct-to-patient telehealth solutions. The company operates a portfolio of distinct brands including Lumir (integrative medicine products - dried flower, tinctures, vapes), High Country, Humming Bud, and Helix (premium medical cannabis products), alongside telehealth clinic brands Lumir Clinic (UK and USA) and Natura. The company also provides a THC Calculator tool for Australian doctors to assist with prescribing decisions within TGA guidelines.
Differentiator
Problem solved
Functional benefit
Brands
- Lumir: Integrative medicine products available as Dried Flower, tinctures and vapes. Named after Professor Lumir Hanuš who discovered Anandamide.
- High Country
- Helix
- Humming Bud
Products and services
- Lumir Integrative medicine products available as dried flower, tinctures, and vapes, branded under Lumir and endorsed via Cannim's medical advisory board.
- High Country Premium medical cannabis products curated by Cannim's experienced curation team from high-quality growers worldwide.
- Humming Bud Hand-selected batch of exceptional medical cannabis medications sourced from top-tier international growers.
- Helix High-quality medical cannabis products positioned for compassionate pricing and accessibility to patients with the greatest need.
- Lumir Clinic UK CQC licensed telehealth clinic in the UK based at the University of Birmingham, led by Dr Anup Matthew, specializing in holistic medical solutions for patients' persistent conditions.
- Lumir Clinic USA US telehealth clinic run by veterans and specializing in healthcare services for US veterans, providing services across the United States.
- Natura (Natura Healthcare / Natura Clinic) Australian boutique clinic offering premium medical cannabis solutions curated from high-quality global growers for demanding patient needs.
Companies that use Cannim
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Cannim technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Cannim partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Western Sydney UniversitycoreResearch partnership for conducting technology and AI-enabled research to prove efficacy of alternative medicines across demographics. One of the research program approval locations.
- University of BirminghamcoreHost institution for Lumir Clinic UK, a CQC licensed telehealth clinic. Led by Dr Anup Matthew. Part of research approval locations for US, UK and Australia programs.
- University of South FloridacoreResearch partner institution for conducting technology and AI-enabled research to prove efficacy of alternative medicines. One of three research program approval locations.
- St. Louis UniversitycoreResearch partnership for conducting research on alternative medicines and efficacy across conditions. Listed among university research partners.
- National Institute of Integrative Medicine (NICM)coreNICM guidelines on daily THC limits (500mg for inhalation, 40mg for oral) are referenced in Cannim's THC Calculator for Australian doctors. Collaborative relationship for clinical guidance.
- Premium Global GrowersminorCannim curates products from select group of premium growers across the world for import and distribution into legal Medical Cannabis markets.
Scale indicators2 records
Recent moves6 records
Expansion highlights7 records
Cannim competitors and assessment
Company assessmentBroad incumbents
- Canopy Growth Corporation: Canopy Growth is a large, multi-jurisdiction cannabis producer and distributor with medical cannabis businesses in Canada, Germany, Australia, and elsewhere. Comparable as a broad incumbent medical cannabis competitor with Australian distribution that competes with Cannim's pharmacy-channel products.
- Jazz Pharmaceuticals (GW Pharmaceuticals): Jazz Pharmaceuticals acquired GW Pharmaceuticals, the originator of cannabis-derived prescription medicines Sativex and Epidiolex. Comparable as an established, well-capitalised player operating in cannabis-based prescription pharmaceuticals with regulatory-grade evidence — the endpoint Cannim is positioning toward with its university research programs.
- Cronos Group: Cronos Group is a global cannabis company operating in Israel, Canada, Germany, and Australia with branded medical cannabis products. Comparable as a broad incumbent with global medical cannabis distribution touching Cannim's pharmacy-channel markets, particularly Australia.
Direct peers
- Tilray Brands: Tilray is a global cannabis producer and distributor with operations across North America, Europe, and Australia/Americas, supplying medical cannabis (dried flower, oils, vapes) through pharmaceutical channels. Directly comparable to Cannim as a multi-jurisdiction importer/distributor of medical cannabis into regulated markets with both B2B and consumer channels.
- Botanix Pharmaceuticals: Botanix is an Australian/American cannabinoid pharmaceutical company developing prescription cannabinoid products through FDA pathways. Comparable as a research-driven, ASX-listed cannabinoid therapeutics company pursuing prescription-grade positioning similar to Cannim's research-led, efficacy-focused thesis.
- Incannex Healthcare: Incannex is an ASX-listed clinical-stage pharmaceutical company developing cannabinoid and psychedelic (psilocybin) therapies for indications including PTSD and anxiety. Comparable as an Australia-based research-led medicinal cannabis/psychedelic therapeutic developer targeting the same patient populations Cannim serves via Lumir Clinic.
- Bod Australia: Bod Australia develops and distributes medicinal cannabis and hemp-derived CBD products primarily in Australia and the UK, with a focus on pharmacy and practitioner channels. Comparable as a branded medicinal cannabis distributor with overlapping geographic footprint (AU and UK) and pharmacy-led go-to-market.
- Little Green Pharma: Little Green Pharma is an ASX-listed Australian medical cannabis manufacturer producing dried flower and oils, selling through pharmacies and direct-to-patient channels. Most directly comparable Australian-listed peer with similar pharmacy-channel distribution and product format overlap (Lumir/High Country/Little Green Pharma dried flower and oils).
- Althea Group Holdings: Althea is an Australian medical cannabis company selling branded cannabis products via B2B pharmacy distribution and patient education platforms. Comparable as a pharmacy-channel Australian medical cannabis distributor with a branded product portfolio competing in the same SKU categories as Cannim's Lumir and High Country brands.
Regional players
- Curaleaf Holdings: Curaleaf is a US multi-state operator of cannabis dispensaries and producer of branded medical/adult-use products. Comparable on the medical cannabis product portfolio and US market focus relevant to Cannim's Lumir Clinic USA, but US-domestic geographic footprint makes it a regional rather than directly competing player for Cannim.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Cannim social profiles
Digital presenceCannim financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cannim leadership team
Management profileNumber of profiles
Profiles8 records
Cannim subsidiaries and ownership
Company hierarchySubsidiaries3 records
Cannim funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cannim M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cannim
What does Cannim do?
Cannim imports and distributes premium medical cannabis products (dried flower, tinctures, vapes) under proprietary brands Lumir, High Country, Humming Bud, and Helix into Australia, the UK, and USA. It also operates wholly-owned telehealth clinics (Lumir Clinic UK, Lumir Clinic USA, Natura Clinic Australia) delivering direct-to-patient consultations and dispensing for chronic and persistent conditions, alongside AI-enabled research programs demonstrating efficacy of cannabis and psilocybin-based therapies.
Is Cannim a public or private company?
Cannim is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cannim founded?
Cannim was founded in 2017. It employs 51 to 100 people.
Where is Cannim based?
Cannim is headquartered in Sydney, Australia, in the Oceania region.
How does Cannim make money?
Two revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are telehealth Clinic Services.
Who are Cannim's main competitors?
Broad incumbents on record are Canopy Growth Corporation, Jazz Pharmaceuticals (GW Pharmaceuticals) and Cronos Group. Direct peers are Tilray Brands, Botanix Pharmaceuticals, Incannex Healthcare, Bod Australia, Little Green Pharma and Althea Group Holdings. Curaleaf Holdings is listed as a regional player.
Does Cannim have an API?
No public API is recorded for Cannim.
What industry is Cannim in?
Cannim's product category is Medical Cannabis. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325412 and its SIC code is 2834.